Boule Diagnostics AB (BOUL) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Boule Diagnostics AB

Stille AB

Senzime AB

OssDsign AB

BrainCool AB

Promimic AB

Enzymatica AB

Mentice AB

Paxman AB

Integrum AB

Curasight A/S

Why is Boule Diagnostics AB ?

Poor long term growth as Operating profit has grown by an annual rate -208.64% of over the last 5 years

The company has declared Negative results for the last 3 consecutive quarters

NET PROFIT(HY) At SEK -6.5 MM has Grown at -179.27%
ROCE(HY) Lowest at -97.55%
RAW MATERIAL COST(Y) Grown by 10.61% (YoY)

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -31.95%, its profits have fallen by -1410.4%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -31.95% returns in the last 1 year, the stock has also underperformed OMX Stockholm 30 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Boule Diagnostics AB should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Boule Diagnostics AB for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Boule Diagnostics AB

-100.0%

-0.42

58.84%

OMX Stockholm 30

8.01%

0.44

18.11%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

3.24%

EBIT Growth (5y)

-208.64%

EBIT to Interest (avg)

-2.33

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

1.04

Sales to Capital Employed (avg)

1.13

Tax Ratio

17.46%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

5.64%

ROE (avg)

5.22%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.20

EV to EBIT

-1.16

EV to EBITDA

-1.24

EV to Capital Employed

1.09

EV to Sales

0.73

PEG Ratio

Dividend Yield

ROCE (Latest)

-94.25%

ROE (Latest)

-172.02%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

No Trend

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company

OPERATING PROFIT(Q)

Highest at SEK 12.8 MM

OPERATING PROFIT MARGIN(Q)

Highest at 9.9 %

PRE-TAX PROFIT(Q)

Highest at SEK 0.5 MM

NET PROFIT(Q)

Highest at SEK -1.2 MM

-20What is not working for the Company

NET PROFIT(HY)

At SEK -6.5 MM has Grown at -179.27%

ROCE(HY)

Lowest at -97.55%

RAW MATERIAL COST(Y)

Grown by 10.61% (YoY

CASH AND EQV(HY)

Lowest at SEK 43 MM

DEBT-EQUITY RATIO (HY)

Highest at 114.37 %

INTEREST(Q)

Highest at SEK 6.5 MM

Here's what is working for Boule Diagnostics AB

Pre-Tax Profit

At SEK 0.5 MM has Grown at 141.67%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (SEK MM)

Operating Profit

Highest at SEK 12.8 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (SEK MM)

Operating Profit Margin

Highest at 9.9 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

Highest at SEK 0.5 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (SEK MM)

Net Profit

Highest at SEK -1.2 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (SEK MM)

Here's what is not working for Boule Diagnostics AB

Interest

At SEK 6.5 MM has Grown at 96.97%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (SEK MM)

Interest

Highest at SEK 6.5 MM

in the last five periods and Increased by 96.97% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (SEK MM)

Cash and Eqv

Lowest at SEK 43 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio

Highest at 114.37 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost

Grown by 10.61% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales